Science 176 , 309310 (1972)
After blocking in 5% skimmed milk powder for 2 hours at room temperature, the samples were incubated overnight at 4C with primary antibodies, including ERK1/2 (#9102), p-ERK1/2 (#9101), JNK1/2 (#9252), p-JNK (#9251), p38 MAPK (#9212), and p-p38 MAPK (#9211), which were obtained from Cell Signaling Technology (Beverly, MA, USA), as well as VEGF-a (sc-7269) and Tubulin (sc-8035), which were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA)
Research shows that the medication does not transfer to breast milk in high levels, posing no harm to the baby
If this occurs, slight dose adjustment (increasing by 50mcg if not already at 500mcg) may help
For those seeking guided peptide therapy, our experienced medical team designs personalized protocols based on clinical goals, medical history, and lab results